Shares of Opko Health, Inc. (NASDAQ:OPK) are currently poised at -1.58% from the open today and are hovering around at $6.24. More than 3,238,258 shares have traded hands versus an average trading volume of 4.35M. At the current PPS, the market capiralization stands at $3.34B. The stock prices of Opko Health, Inc. (NASDAQ:OPK) are currently trading at -48.64% below its 52 week high and 4.17% above its 52 week low.
OPKO Health, Inc. (NASDAQ:OPK) announces it has entered into agreements with several large Medicare Part D plan sponsors, including the largest Medicare Part D plan, and additional commercial insurance plans for reimbursement of RAYALDEE(R) (extended-release calcifediol), which expands the percentage of insured lives with access to RAYALDEE to approximately 68% as of June 1, 2017.
Opko Health, Inc. (NASDAQ:OPK) is all set to post its earnings on May 08. As per Zack’s analyst ratings, Opko Health, Inc. (NASDAQ:OPK) has an average brokerage rating of 1.4. On a scale of 1-5, a rating of 1 or 2 would show a buy, and a score of 4 or 5 would indicate a sell call. A rating of 3 would suggest a hold on the stock. The consensus price on (NASDAQ:OPK) is $12.125 with a high of $19.5 and a low of $8.
Let’s take a look at the technical analysis.
The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.
The Exponential Moving Average is similar to a simple moving average however it utilizes a weighting cog that exponentially drops from the recent data point. The study of EMA compares the short term, intermediate term and long term EMAs. The respective EMAs tend to give bullish signals when hovering above trailing EMAs and below the latest price and vice versa. EMA alerts constitute crossovers i.e. the 5-day EMA crosses below/above the 20 day EMA and EMA convergences 5-day EMA comparable to 13 day EMA. The 5 day EMA 6.35 is higher than the last trade price suggesting a short term bearish pattern building up. Long term, the 50 day EMA 7.14 is also higher than the current trading price depicting a bearish trend overall.
The relative strength index (RSI) can be defined as a momentum oscillator that can compute measure the velocity and extent of stock price changes. Momentum is computed as the ratio of positive price variations to negative price changes. The RSI study compares the current Relative Strength Index against oversold (30), overbought (70) and neutral (50) conditions. Alerts will apprise you when shares recede from oversold/overbought marks or breakthrough neutral (50). The current RSI is 37.53 suggesting a bearish price action.
Though Opko Health, Inc. (NASDAQ:OPK) represents an exciting growth story open to numerous attractive markets, it would be remarkable to see how it does for long-term investors.